Vaginal cancer epidemiology and demographics

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Syed Musadiq Ali M.B.B.S.[2]

Vaginal cancer Microchapters


Patient Information


Historical Perspective




Differentiating Vaginal cancer from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


History and Symptoms

Physical Examination


Laboratory Findings

X Ray




Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vaginal cancer epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Vaginal cancer epidemiology and demographics

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vaginal cancer epidemiology and demographics

CDC on Vaginal cancer epidemiology and demographics

Vaginal cancer epidemiology and demographics in the news

Blogs on Vaginal cancer epidemiology and demographics

Directions to Hospitals Treating Vaginal cancer

Risk calculators and risk factors for Vaginal cancer epidemiology and demographics


In 2015, the incidence of vaginal cancer is approximately 2-3 per 100,000 individuals with a death number of 910.

Epidemiology and Demographics

  • New cases: 4,070.
  • Deaths: 910.
  • New cases: 2,210.
  • Deaths: 760.


  1. Gadducci A, Fabrini MG, Lanfredini N, Sergiampietri C (March 2015). "Squamous cell carcinoma of the vagina: natural history, treatment modalities and prognostic factors". Crit. Rev. Oncol. Hematol. 93 (3): 211–24. doi:10.1016/j.critrevonc.2014.09.002. PMID 25476235.
  2. Siegel RL, Miller KD, Jemal A (2015). "Cancer statistics, 2015". CA Cancer J Clin. 65 (1): 5–29. doi:10.3322/caac.21254. PMID 25559415.
  3. Shah CA, Goff BA, Lowe K, Peters WA, Li CI (May 2009). "Factors affecting risk of mortality in women with vaginal cancer". Obstet Gynecol. 113 (5): 1038–45. doi:10.1097/AOG.0b013e31819fe844. PMC 2746762. PMID 19384118.
  4. Alemany L, Saunier M, Tinoco L, Quirós B, Alvarado-Cabrero I, Alejo M, Joura EA, Maldonado P, Klaustermeier J, Salmerón J, Bergeron C, Petry KU, Guimerà N, Clavero O, Murillo R, Clavel C, Wain V, Geraets DT, Jach R, Cross P, Carrilho C, Molina C, Shin HR, Mandys V, Nowakowski AM, Vidal A, Lombardi L, Kitchener H, Sica AR, Magaña-León C, Pawlita M, Quint W, Bravo IG, Muñoz N, de Sanjosé S, Bosch FX (November 2014). "Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples". Eur. J. Cancer. 50 (16): 2846–54. doi:10.1016/j.ejca.2014.07.018. PMID 25155250.
  5. Daling JR, Madeleine MM, Schwartz SM, Shera KA, Carter JJ, McKnight B, Porter PL, Galloway DA, McDougall JK, Tamimi H (February 2002). "A population-based study of squamous cell vaginal cancer: HPV and cofactors". Gynecol. Oncol. 84 (2): 263–70. doi:10.1006/gyno.2001.6502. PMID 11812085.
  6. Vinokurova S, Wentzensen N, Einenkel J, Klaes R, Ziegert C, Melsheimer P, Sartor H, Horn LC, Höckel M, von Knebel Doeberitz M (December 2005). "Clonal history of papillomavirus-induced dysplasia in the female lower genital tract". J. Natl. Cancer Inst. 97 (24): 1816–21. doi:10.1093/jnci/dji428. PMID 16368943.